22-28695049-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_007194.4(CHEK2):c.1375+78C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.641 in 860,542 control chromosomes in the GnomAD database, including 178,783 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.61 ( 28239 hom., cov: 32)
Exomes 𝑓: 0.65 ( 150544 hom. )
Consequence
CHEK2
NM_007194.4 intron
NM_007194.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.158
Publications
12 publications found
Genes affected
CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
CHEK2 Gene-Disease associations (from GenCC):
- CHEK2-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- Li-Fraumeni syndrome 2Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- acute myeloid leukemiaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 22-28695049-G-C is Benign according to our data. Variant chr22-28695049-G-C is described in ClinVar as Benign. ClinVar VariationId is 1254473.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.606 AC: 92012AN: 151944Hom.: 28229 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
92012
AN:
151944
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.649 AC: 459918AN: 708480Hom.: 150544 AF XY: 0.655 AC XY: 246694AN XY: 376848 show subpopulations
GnomAD4 exome
AF:
AC:
459918
AN:
708480
Hom.:
AF XY:
AC XY:
246694
AN XY:
376848
show subpopulations
African (AFR)
AF:
AC:
9757
AN:
19024
American (AMR)
AF:
AC:
24696
AN:
39060
Ashkenazi Jewish (ASJ)
AF:
AC:
14747
AN:
20658
East Asian (EAS)
AF:
AC:
24389
AN:
35106
South Asian (SAS)
AF:
AC:
50116
AN:
68064
European-Finnish (FIN)
AF:
AC:
33182
AN:
50028
Middle Eastern (MID)
AF:
AC:
2740
AN:
4054
European-Non Finnish (NFE)
AF:
AC:
278186
AN:
437644
Other (OTH)
AF:
AC:
22105
AN:
34842
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8359
16719
25078
33438
41797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3644
7288
10932
14576
18220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.605 AC: 92049AN: 152062Hom.: 28239 Cov.: 32 AF XY: 0.606 AC XY: 45042AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
92049
AN:
152062
Hom.:
Cov.:
32
AF XY:
AC XY:
45042
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
21048
AN:
41474
American (AMR)
AF:
AC:
8903
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
2485
AN:
3472
East Asian (EAS)
AF:
AC:
3278
AN:
5162
South Asian (SAS)
AF:
AC:
3609
AN:
4820
European-Finnish (FIN)
AF:
AC:
6857
AN:
10552
Middle Eastern (MID)
AF:
AC:
201
AN:
294
European-Non Finnish (NFE)
AF:
AC:
43710
AN:
67982
Other (OTH)
AF:
AC:
1334
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1841
3683
5524
7366
9207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2516
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.